32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
King B, Ohyama M, Mostaghimi A. 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2. Journal Of The American Academy Of Dermatology 2022, 87: ab33. DOI: 10.1016/j.jaad.2022.06.165.Peer-Reviewed Original ResearchPatient evaluationHair loss